What medication is available and what are the side effects? Medication can be helpful in improving the main symptoms of ...

Certain cancers and Parkinson's disease are especially difficult to treat, because many of the disease relevant proteins are ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

KinCon biolabs, a spin-off from the University of Innsbruck, is expanding its patented platform technology to support ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

The pair had exploited the vulnerable occupant of the address, in order to use his home as a base to deal drugs from – often called Cuckooing. Parkinson was jailed for 37 months for the offences, ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.